Overview Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Status: Completed Trial end date: 2016-08-01 Target enrollment: Participant gender: Summary The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat. Phase: Phase 3 Details Lead Sponsor: Kythera Biopharmaceuticals